Lymphoma, Large B-Cell, Diffuse  >>  Gazyva (obinutuzumab)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Gazyva (obinutuzumab) / Roche, Biogen
GATHER, NCT01414855: A Study of Obinutuzumab [RO5072759 (GA101)] in Combination With CHOP Chemotherapy in Patients With Previously Untreated Advanced Diffuse Large B-Cell Lymphoma

Checkmark ASH 2013
Nov 2013 - Nov 2013: ASH 2013
Checkmark ASH 2013
Nov 2013 - Nov 2013: ASH 2013
Completed
2
100
US
obinutuzumab, cyclophosphamide, doxorubicin, prednisone, vincristine
Genentech, Inc.
Lymphoma, B-Cell
12/13
12/16

Download Options